All studies
AuthorisedPhase II and Phase III (Integrated)Interventional

A Multicentre, Parallel-Group, Observer-Blind, Randomised, Placebo-Controlled, Pivotal Trial Investigating the Safety and Immunogenicity of Group B Streptococcus Vaccine (GBS-NN/NN2) in Pregnant Women and Infants Born to Pregnant Women Vaccinated During Pregnancy

Group B Streptococcus (GBS) is a common bacteria carried naturally by many adults without causing any symptoms. However, it can occasionally pass to a baby during labour, leading to severe and life-threatening conditions such as sepsis, pneumonia, or meningitis. Currently, there is no vaccine available to prevent GBS in babies. This study is testing an experimental vaccine called GBS-NN/NN2. Pregnant women taking part will receive either the vaccine or a harmless saltwater injection (a placebo). Doctors want to see if the vaccine helps mothers produce protective proteins, called antibodies, which naturally cross the placenta into the baby's bloodstream. After birth, researchers will test the baby's blood to see if they have enough antibodies to help fight off GBS. The goal is to find out if this vaccine is safe and effective at protecting newborn babies in their earliest weeks of life.

At a glance

Status
Authorised
Phase
Phase II and Phase III (Integrated)
Sponsor
Minervax ApS
Enrolment target
620
Start
18 Sep 2026

What is this study about?

Group B Streptococcus (GBS) is a type of bacteria that lives naturally in the intestines or vagina of about one in four women. In healthy adults, it causes no harm. However, during pregnancy and birth, the bacteria can spread to the baby. While most babies remain well, a small number develop dangerous infections like blood poisoning (sepsis) or swelling around the brain (meningitis).

At present, the main way to protect newborns is to give intravenous antibiotics during labour to mothers who carry the bacteria. While this helps reduce infections in the first few days of life, it does not protect babies who develop illness later in their first few months, and it requires knowing in advance who carries the bacteria. A maternal vaccine could offer babies continuous protection from the moment they are born.

This clinical trial is testing whether giving the GBS-NN/NN2 vaccine during pregnancy is safe and helps mothers make protective antibodies. These antibodies travel through the placenta to the baby before birth. By measuring the level of antibodies in babies at birth, researchers hope to confirm whether maternal vaccination can build a strong shield against GBS infection.

Key takeaways

  • The study tests a new vaccine given during pregnancy to protect newborn babies from Group B Strep.
  • Half of the participants will receive the vaccine, and half will receive a harmless saltwater injection.
  • Antibodies from the mother are expected to pass across the placenta to protect the baby after birth.
  • Your routine pregnancy and delivery care will continue as normal throughout the trial.
  • Joining is completely voluntary, and you can withdraw at any time.

Who may be eligible?

This study is open to pregnant women aged 18 and older who are expecting a single baby and are in good general health. Because the trial tracks protection passed to the baby, participants must be comfortable with their baby also being monitored after birth.

You will need to be at a specific stage of your pregnancy—usually in the second or third trimester—when receiving the injection. The study team will review your health history and your pregnancy so far to make sure taking part is completely safe for you and your baby.

You might not be eligible if you have certain medical conditions, severe allergies to vaccines, or complications with your pregnancy. The study doctors will go through all the medical criteria with you in detail before you make any decisions.

Could this study suit you?

Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.

  1. I am aged 18 or older.
  2. I am currently pregnant with a single baby.
  3. I am in the second or third trimester of my pregnancy (or approaching it).
  4. I do not have any major uncontrolled medical conditions or severe vaccine allergies.
  5. I am happy for my baby's health to be monitored after birth.
Answer every question to see your result.

What does participation involve?

If you join the study, you will receive one injection in your upper arm during your pregnancy. You will be randomly assigned to receive either the trial vaccine or a dummy injection (a sterile saltwater solution). Neither you nor the study team will know which one you received until the study is over.

You will attend a few routine study visits during your pregnancy for health checks and blood samples. After your baby is born, the team will collect a small blood sample (often from the umbilical cord) to check antibody levels. Your baby will then be monitored during their first few months of life with routine, gentle check-ups. Overall, your participation will last from late pregnancy until your baby is several months old.

Potential risks and benefits

Taking part may not help you directly, but it could help develop a vaccine that protects future babies from life-threatening infections. If you receive the vaccine, your baby may gain protection against GBS. Common side effects are usually mild and similar to standard vaccines, such as soreness or redness where the injection was given, mild tiredness, or a low fever. Taking part is completely your choice, and you can change your mind and leave the study at any time without any impact on your normal NHS maternity care.

Locations (4)

Some site locations are approximate. We're improving this — please verify with the trial team before travelling.
  • —
    Unverified
    Czechia
  • —
    Unverified
    Belgium
  • —
    Unverified
    Denmark
  • —
    Unverified
    Spain

Common questions

Can the trial vaccine give me or my baby a GBS infection?

No. The vaccine does not contain live bacteria, so it cannot cause a Group B Strep infection in either you or your baby.

Will taking part change my birth plan?

No. You can still follow your chosen birth plan and receive all standard NHS care, including antibiotics during labour if your midwife or doctor recommends them.

Why is a placebo (saltwater injection) used?

Comparing the vaccine to a harmless saltwater injection is the best way to prove that any immune response or side effects are truly caused by the vaccine.

Will my baby have to go through painful procedures?

The study team aims to collect blood from the umbilical cord after birth, which is completely painless. Any follow-up checks are designed to be as gentle as possible.

Can I leave the study if I change my mind?

Yes. You are free to stop taking part at any stage without giving a reason, and your medical care will not be affected in any way.

How to find out more

Always speak to your GP or specialist before deciding to take part in a study.

Discussion

Community discussion

Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.